Frederik E. Stuurman

911 total citations
40 papers, 662 citations indexed

About

Frederik E. Stuurman is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Frederik E. Stuurman has authored 40 papers receiving a total of 662 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 14 papers in Pulmonary and Respiratory Medicine and 7 papers in Molecular Biology. Recurrent topics in Frederik E. Stuurman's work include Cancer Treatment and Pharmacology (9 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Cancer therapeutics and mechanisms (5 papers). Frederik E. Stuurman is often cited by papers focused on Cancer Treatment and Pharmacology (9 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Cancer therapeutics and mechanisms (5 papers). Frederik E. Stuurman collaborates with scholars based in Netherlands, United States and France. Frederik E. Stuurman's co-authors include Jan H.M. Schellens, Jos H. Beijnen, Bastiaan Nuijen, Adam F. Cohen, R.C.A. Schellekens, Henderik W. Frijlink, Jos G. W. Kosterink, Matthijs D. Kruizinga, Jacobus Burggraaf and Frans Stellaard and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Frederik E. Stuurman

40 papers receiving 648 citations

Peers

Frederik E. Stuurman

ONCOL

PRM

BIOMA

Dominik Selzer Germany

Mario Eandi Italy

Emil Samara United States

Marit D Moen New Zealand

Silvia De Francia Italy

Martin Czejka Austria

Yoshiki Suzuki Japan

Alyson Connor United Kingdom

Stephanie E. Easthope New Zealand

Sandhiya Selvarajan India

Dominik Selzer Germany

Frederik E. Stuurman

122 ×0.9

ONCOL

253 ×2.2

149 ×1.4

98 ×1.0

PRM

82 ×1.3

BIOMA

Citations per year, relative to Frederik E. Stuurman Frederik E. Stuurman (= 1×) peers Dominik Selzer

Countries citing papers authored by Frederik E. Stuurman

Since Specialization

Citations

This map shows the geographic impact of Frederik E. Stuurman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frederik E. Stuurman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frederik E. Stuurman more than expected).

Fields of papers citing papers by Frederik E. Stuurman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frederik E. Stuurman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frederik E. Stuurman. The network helps show where Frederik E. Stuurman may publish in the future.

Co-authorship network of co-authors of Frederik E. Stuurman

This figure shows the co-authorship network connecting the top 25 collaborators of Frederik E. Stuurman. A scholar is included among the top collaborators of Frederik E. Stuurman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frederik E. Stuurman. Frederik E. Stuurman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kruizinga, Matthijs D., Hao Dang, Frederik E. Stuurman, et al.. (2025). Physical recovery after local resection of nonpedunculated rectal adenomas and T1 carcinomas: endoscopic submucosal dissection versus transanal minimally invasive surgery. Gastrointestinal Endoscopy. 102(4). 583–592.e6. 1 indexed citations

Radanović, Igor, Milan Kos, Jan W. Schoones, et al.. (2023). Smartphone-Based Passive Sensing in Monitoring Patients With Cancer: A Systematic Review. JCO Clinical Cancer Informatics. 7(7). e2300141–e2300141. 5 indexed citations

Ferreira, Guilherme S., Désirée H. Veening-Griffioen, Wouter Boon, et al.. (2023). Translatability of preclinical to early clinical tolerable and pharmacologically active dose ranges for central nervous system active drugs. Translational Psychiatry. 13(1). 74–74. 3 indexed citations

Kaay, Daniëlle C M van der, et al.. (2022). Objective Home-Monitoring of Physical Activity, Cardiovascular Parameters, and Sleep in Pediatric Obesity. SHILAP Revista de lepidopterología. 6(1). 19–30. 3 indexed citations

Vries, Esther de, Bhavna Solanki, Jaskaran Singh, et al.. (2022). The effects of intranasal esketamine on on-road driving performance in patients with major depressive disorder or persistent depressive disorder. Journal of Psychopharmacology. 36(5). 614–625. 7 indexed citations

Kruizinga, Matthijs D., et al.. (2021). Towards remote monitoring in pediatric care and clinical trials—Tolerability, repeatability and reference values of candidate digital endpoints derived from physical activity, heart rate and sleep in healthy children. PLoS ONE. 16(1). e0244877–e0244877. 18 indexed citations

Kruizinga, Matthijs D., et al.. (2021). Postdischarge Recovery after Acute Pediatric Lung Disease Can Be Quantified with Digital Biomarkers. Respiration. 100(10). 979–988. 7 indexed citations

Kruizinga, Matthijs D., et al.. (2021). Development and Technical Validation of a Smartphone-Based Cry Detection Algorithm. Frontiers in Pediatrics. 9. 651356–651356. 9 indexed citations

Kruizinga, Matthijs D., Frederik E. Stuurman, Vasileios Exadaktylos, et al.. (2020). Development of Novel, Value-Based, Digital Endpoints for Clinical Trials: A Structured Approach Toward Fit-for-Purpose Validation. Pharmacological Reviews. 72(4). 899–909. 34 indexed citations

10.

Grievink, Hendrika W., Frederik E. Stuurman, Marieke L. de Kam, et al.. (2019). Immunomonitoring of Tacrolimus in Healthy Volunteers: The First Step from PK- to PD-Based Therapeutic Drug Monitoring?. International Journal of Molecular Sciences. 20(19). 4710–4710. 13 indexed citations

11.

Kruizinga, Matthijs D., Frederik E. Stuurman, Geert Jan Groeneveld, & Adam F. Cohen. (2019). The Future of Clinical Trial Design: The Transition from Hard Endpoints to Value-Based Endpoints. Handbook of experimental pharmacology. 260. 371–397. 16 indexed citations

12.

Esdonk, Michiel J. van, et al.. (2019). The Pharmacodynamic Effects of a Dopamine–Somatostatin Chimera Agonist on the Cardiovascular System. Journal of Cardiovascular Pharmacology. 74(2). 128–136. 4 indexed citations

13.

Weger, Vincent A. de, Frederik E. Stuurman, Stijn L.W. Koolen, et al.. (2019). A Phase I Dose Escalation Study of Once-Weekly Oral Administration of Docetaxel as ModraDoc001 Capsule or ModraDoc006 Tablet in Combination with Ritonavir. Clinical Cancer Research. 25(18). 5466–5474. 16 indexed citations

14.

Burylo, Artur M, Vincent A. de Weger, Frederik E. Stuurman, Jos H. Beijnen, & Jan H.M. Schellens. (2017). Enrichment of Circulating Endothelial Cells by CD34 Microbeads Followed by Enumeration Using Flow Cytometry. Thrombosis and Haemostasis. 117(12). 2356–2368. 1 indexed citations

15.

Weger, Vincent A. de, Frederik E. Stuurman, Jeroen J. M. A. Hendrikx, et al.. (2017). A dose-escalation study of bi-daily once weekly oral docetaxel either as ModraDoc001 or ModraDoc006 combined with ritonavir. European Journal of Cancer. 86. 217–225. 22 indexed citations

16.

Heuberger, Jules A. A. C., Joris I. Rotmans, Pim Gal, et al.. (2017). Effects of erythropoietin on cycling performance of well trained cyclists: a double-blind, randomised, placebo-controlled trial. The Lancet Haematology. 4(8). e374–e386. 36 indexed citations

17.

Weger, Vincent A. de, Frederik E. Stuurman, Marja Mergui‐Roelvink, et al.. (2016). A phase I dose-escalation trial of bi-daily (BID) weekly oral docetaxel as ModraDoc006 in combination with ritonavir. Annals of Oncology. 27. vi127–vi127. 2 indexed citations

18.

Stuurman, Frederik E., Emile E. Voest, Ahmad Awada, et al.. (2013). Phase I study of oral CP-4126, a gemcitabine derivative, in patients with advanced solid tumors. Investigational New Drugs. 31(4). 959–966. 29 indexed citations

19.

Stuurman, Frederik E., Bastiaan Nuijen, Jos H. Beijnen, & Jan H.M. Schellens. (2013). Oral Anticancer Drugs: Mechanisms of Low Bioavailability and Strategies for Improvement. Clinical Pharmacokinetics. 52(6). 399–414. 117 indexed citations

20.

Schellekens, R.C.A., et al.. (2008). Pulsatile drug delivery to ileo-colonic segments by structured incorporation of disintegrants in pH-responsive polymer coatings. Journal of Controlled Release. 132(2). 91–98. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact